Please assess the completion status of the following clinical trial:

Trial Title: Measurement of Gastric Emptying During and After COLOKIT® Intake

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject who signed an informed consent to participate in the trial.~* Subject affiliated with Social Security~* Men and women aged 18 to 75 years.~* Subject with an indication of scheduled outpatient colonoscopy.~* colonoscopy performed within six hours after the second sequence COLOKIT®.~* Subject able to swallow tablets.~Exclusion Criteria:~1. Women pregnant or likely to be (without contraception) or nursing.~2. Subject having any of the following diseases or conditions:~   * allergy or hypersensitivity to the product tested or any of its excipients,~  * nausea, vomiting or abdominal pain,~  * clinically significant renal failure,~  * primary hyperparathyroidism associated with hypercalcemia,~  * congestive heart failure,~  * ascites,~  * a known or suspected bowel obstruction,~  * megacolon (congenital or acquired)~  * intestinal perforation,~  * ileus,~  * an inflammatory disease or suspected inflammatory bowel disease,~  * swallowing disorders,~  * known digestive motor disorders (gastroparesis, scleroderma, mega-esophagus),~  * diabetes mellitus (insulin or non insulin-dependent)~  * a history of gastric surgery (partial or total)~  * a contraindication to the anesthesia required for the completion of the colonoscopy,~  * Any clinical condition which, in the opinion of the investigator, would not allow the subject to perform the test in good conditions.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- COLOKIT® (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).